Login
$ROIV
$39.11 +$0.50 (1.3%) After hours

$ROIV 4 SEC Filings

Filed On Filing
12 Nov 2026 Form 4: Torti Frank, President and Vant Chair

Disposed of 392,052 shares (Other Transaction) ($16M) · Disposed of 392,048 shares (Other Transaction) ($16.4M) · Disposed of 392,043 shares (Other Transaction) ($15.9M) · 1 more

12 Nov 2026 Form 4: Gline Matthew, Director

Disposed of 58,331 shares (Other Transaction) ($2.38M) · Disposed of 48,988 shares (Other Transaction) ($2.05M) · Disposed of 48,988 shares (Other Transaction) ($1.98M) · 1 more

12 Nov 2026 Form 4: Sukhatme Mayukh, Director

Disposed of 59,034 shares (Other Transaction) ($2.41M) · Disposed of 53,205 shares (Other Transaction) ($2.22M) · Disposed of 53,205 shares (Other Transaction) ($2.15M) · 1 more

12 Nov 2026 Form 4: Pulik Richard, CFO

Received 125,000 shares by exercise or conversion ($481K) · Sold 125,000 shares ($5.15M) · Received 127,365 shares by exercise or conversion ($490K) · 1 more

12 Nov 2026 Form 4: Venker Eric, President & Immunovant CEO

Sold 187,943 shares ($7.62M)

05 Nov 2026 Form 4: Venker Eric, President & Immunovant CEO

Sold 200,000 shares ($7.26M)

30 Oct 2026 Form 4: Venker Eric, President & Immunovant CEO

Sold 200,000 shares ($7.32M)

27 Oct 2026 Form 4: Oren Ilan, Director

Received 810 shares as a grant or award

27 Oct 2026 Form 4: Epperly Melissa B,, Director

Received 513 shares as a grant or award · Gave up 116 shares to cover exercise price or tax ($4.23K)

27 Oct 2026 Form 4: Momtazee James C, Director

Received 383 shares as a grant or award · Gave up 77 shares to cover exercise price or tax ($2.81K)

22 Oct 2026 Form 4: Venker Eric, President & Immunovant CEO

Sold 200,000 shares ($7.02M)

20 Oct 2026 Form 4: Sukhatme Mayukh, Director

Gave up 19,976 shares to cover exercise price or tax ($670K)

20 Oct 2026 Form 4: Gline Matthew, Director

Gave up 34,638 shares to cover exercise price or tax ($1.16M)

05 Oct 2026 Form 4: Roivant Sciences Ltd., Director · Arbutus Biopharma Corp

Returned 8,967,383 shares to the issuer ($44.8M)

05 Oct 2026 Form 4: Epperly Melissa B,, Director

Received 17,750 shares by exercise or conversion ($79.2K) · Sold 17,750 shares ($641K)

02 Oct 2026 Form 4: Gline Matthew, Director

Gave up 76,171 shares to cover exercise price or tax ($2.79M)

02 Oct 2026 Form 4: Torti Frank, President and Vant Chair

Acquired 40,309 shares (Exercise Price / Tax Payment) ($1.47M)

02 Oct 2026 Form 4: Sukhatme Mayukh, Director

Gave up 46,879 shares to cover exercise price or tax ($1.71M)

02 Oct 2026 Form 4: Venker Eric, President & Immunovant CEO

Received 200,000 shares by exercise or conversion ($770K) · Sold 200,000 shares ($7.32M)

22 Sep 2026 Form 4: Humes Jennifer, Chief Accounting Officer

Gave up 3,880 shares to cover exercise price or tax ($154K)

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Premium Feature

This feature requires a premium subscription to unlock unlimited historical data and advanced analysis tools.

Premium includes:

  • Unlimited historical financial data
  • Advanced analytics and insights
  • Priority support